News | April 29, 2023
Biocon Biologics' new mAbs facility receives EU GMP Certification for bBevacizumab
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
Getinge has a strong market share in India within several product segments
Pfizer’s total cumulative revenue from Seagen therapies is expected to reach $36 billion by 2028, according to GlobalData, a leading data and analytics company.
The patent was granted for creating a green catalyst for one of the world's most significant chemical reactions
New Building at Rockford, Illinois site will significantly increase equipment and capacity for injectable biologics and other self-administered therapies
Proposed combination enhances Pfizer’s position as a leading company in oncology
IIT Kanpur pioneers ground-breaking gene therapy technology for Hereditary Eye Diseases
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
Fluor is providing architectural and engineering services and procuring equipment for the new 275,000 square-foot manufacturing facility that will house two manufacturing lines to double manufacturing capability
Subscribe To Our Newsletter & Stay Updated
